Erratum: Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (Antimicrobrial Agents and Chemotherapy (2001) 45:11 (3122-3127))

Eitemau Tebyg

• Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (vol 45, pg 3122, 2001)
  gan: Imwong, M, et al.
  Cyhoeddwyd: (2002)
• Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
  gan: Imwong, M, et al.
  Cyhoeddwyd: (2001)
• Plasmodium vivax: polymerase chain reaction amplification artifacts limit the suitability of pvgam1 as a genetic marker.
  gan: Imwong, M, et al.
  Cyhoeddwyd: (2001)
• Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
  gan: Peto, T, et al.
  Cyhoeddwyd: (1985)
• Sulfadoxine-pyrimethamine for the treatment of malaria.
  gan: White, N
  Cyhoeddwyd: (1991)